INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2002

Shiitake mushroom mycelium extract did not lower PSA levels in prostate cancer.

Sixty-two men with histologically proven prostate cancer and elevated PSA received shiitake mushroom mycelium extract capsules three times daily for 6 months. Among 61 assessable patients, zero achieved a complete or partial PSA response, 23 developed disease progression, and 38 maintained stable PSA levels. When pre-study PSA trajectories were examined, only 4 of 61 patients (7%) demonstrated stabilized disease while taking the supplement.

Study type
Open-label clinical trial
Who was studied
62 men with histologically proven prostate cancer (mean age 73.2 years)
What was measured
Prostate-specific antigen response

THE PAPER

Effects of a mushroom mycelium extract on the treatment of prostate cancer.

deVere White RW, Hackman RM, Soares SE, Beckett LA, Sun B. Urology, 2002.

PubMed 12385925 ↗DOI 10.1016/s0090-4295(02)01856-3 ↗

CancerTop 21: Mushrooms

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.